您好,欢迎来到皮书数据库! 登录|注册
您现在所在的位置:首页  > 中国区域发展数据库
课题组动态
  • ·
  • ·
  • ·
  • ·
  • ·
  • ·
更多>> 专题子库
突发公共卫生事件与应急管理
    新冠肺炎疫情的到来给中国公共卫生应急体系带来了一次大考。以... 详情>>
更多>> 皮书作者
谢伏瞻
    中国社会科学院院长、党组书记,学部委员,学部主席团主席,研究员,博士生导师。历任国务院发展研究中心副主任、国家统... 详情>>
蔡 昉
    1956年9月生于北京。现任中国社会科学院副院长、党组成员,曾任中国社会科学院人口与劳动经济研究所所长,博士生导师,研... 详情>>
李培林
    男,山东济南人。博士,研究员,中国社会科学院副院长,中国社会学会副会长,中国社会科学院社会学研究所副所长。《社会... 详情>>

    2015~2019年“创新药”夯实生物医药产业创新高地:进展、动力与展望

    摘要

    浦东新区是上海生物医药产业发展的核心基地,近年来产业增长势头强劲,支柱地位日益凸显,创新策源能力不断提升,重大新药创制取得重要突破,产业空间布局大幅度扩容。浦东新区生物医药的产业发展以实现技术创新与产业化对接、构建完整产业生态链以及面向国家抗疫防控需求为主要动力。在未来进一步打造成国际知名的生物医药产业创新策源地,对标国际领先地区,打造全球卓越制造基地的发展愿景下,浦东新区应通过机制创新、重点聚焦、政策引导和环境建设,进一步加强研发创新资源和产业发展资源集聚,鼓励龙头企业和骨干企业做大做强,促进新药研发成果转化和产业化,优化生物医药企业营商环境,加快推进生物医药产业高端化、智能化、国际化发展。

    <<
    >>

    Abstract

    Pudong New Area is Shanghai’s important base of the development of biomedical industry. In recently years,its biomedical industry shows strong growth momentum,increasingly highlights its pillar position,constantly upgrades its capability on starting-up innovation,makes major breakthroughs on the creation and manufacture of the innovative medicines,and greatly expands its industrial spatial layout. The development of biomedical industry in Pudong New Area owns three driving forces:the link between technological innovation and industrialization,the establishment of the complete industrial ecological chain,and to meet the demand of the prevention and control of COVID-19 epidemic situation for the nation. In order to further build the innovation birthplace of biomedical industry with international reputation,as while as to build the global manufacturing excellent base which benchmarks international leading regions,with the help of mechanism innovation,focusing with keys,policy guidance and environmental construction,Pudong New Area should further strengthen the agglomeration of innovation and industry development sources,encourage the leading enterprises and key enterprises becoming bigger and stronger,promote achievement transformation and industrialization of the new medicines,optimize business environment of biomedical enterprises,thus accelerating the progress of its biomedical industry with high-end,intellectualization and internationalization.

    <<
    >>
    作者简介
    张申:张申,经济学博士,上海社会科学院经济研究所助理研究员,主要研究方向为产业发展与产业政策。
    <<
    >>
    相关报告